Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ExThera Medical Corporation

Revolutionary Trial Aims to Transform Pancreatic Cancer Treatment
From ExThera Medical Corporation
Via Business Wire
Blood Filtration Offers Hope in the Fight Against Pancreatic Cancer
From ExThera Medical Corporation
Via Business Wire
Breakthrough Technology Study for Patients Suffering From Life-threatening Bloodstream Infections Proceeds Into Next Phase With First Patient Enrollment
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Announces Formation of New Business Advisory Board
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Taps Current Board Member and Top Finance Executive to Take the Helm
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Awarded U.S. Federal Supply Schedule Contract for Seraph 100 Blood Filter
From ExThera Medical Corporation
Via Business Wire
FDA Grants ExThera Multiple Breakthrough Device Designations for its Seraph® 100 Filter
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Receives Certification for Medical Device Single Audit Program (MDSAP) and Recertification for International Organization for Standardization for Medical Devices (ISO 13485)
From ExThera Medical Corporation
Via Business Wire
ExThera Medical in Growth Mode after FDA Approval of Investigational Device Exemption
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBindTM Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients with Pancreatic Cancer
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Exhibits at the 2023 International Conference on Extracorporeal Organ Support in Zagreb, Croatia
From ExThera Medical Corporation
Via Business Wire
Brooke Army Medical Center (BAMC) Establishes Clinical Utility of Seraph 100 for Critically Ill Patients Suffering from Septic Shock Caused by Multiple Pathogens Including Candida
From ExThera Medical Corporation
Via Business Wire
ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock
From ExThera Medical Corporation
Via Business Wire
Results Published for Seraph 100 Treatment of COVID-19 Confirm Survival Benefit Signal
From ExThera Medical Corporation
Via Business Wire
ExThera Medical & Fresenius Medical Care Sign Distribution Agreement for Seraph 100 Blood Purification Device in Mexico
From ExThera Medical Corporation
Via Business Wire
Patient Enrollment is Complete in the DOD-Funded Study of Extracorporeal Hemopurification of Critically Ill COVID-19 Patients
From ExThera Medical Corporation
Via Business Wire
Treatment for Critically Ill COVID Patients Results in Significant Improvement in Survival Rate According to New Study
From ExThera Medical Corporation
Via Business Wire
ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill
From ExThera Medical Corporation
Via Business Wire
Treatment for Critically Ill COVID Patients Begins 1st Randomized Clinical Trial
From ExThera Medical Corporation
Via Business Wire
Clinical Trial for Groundbreaking Device to Treat Septic Shock set to Begin
From ExThera Medical Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.